Top Stories
-
In people with dementia, delirium during COVID-19 is more common but deaths from COVID-19 are not disproportionately higher, finds a new study.
Topic
-
New research may lead to the development of drugs to prevent the nerve damage and pain many cancer patients experience during chemotherapy.
Topic
-
Cells used to study the human blood-brain barrier in the lab aren’t what they seem, a new study has found, throwing nearly a decade’s worth of research into question.
Topic
-
A new Columbia study suggests that malfunctioning endosomes—a central trafficking station inside neurons—are commonly involved in the appearance of Alzheimer’s disease.
Topic
Latest News
- January 22, 2019
A new study by Columbia researchers suggests aspirin may lower stroke risk among middle-aged women with a history of preeclampsia.
Topic
- December 28, 2018
Columbia neurologists and engineers are developing what would be the first wearable diagnostic device for traumatic brain injury.
Topic
- December 17, 2018
A new study shows how cellular “housekeeping” protects some neurons against the toxic proteins of Alzheimer’s disease and suggests new treatment possibilities.
Topic
- November 28, 2018
Increasingly, transformative therapies are being launched via startups emerging from university research labs, including those at Columbia’s Vagelos College of Physicians and Surgeons.
Topic
- November 26, 2018
Scientists initially believed Alzheimer's would be a simple, straightforward problem to solve, but now Columbia researchers are looking for unusual and untried solutions.
Topic
- November 19, 2018
A new program at Columbia is looking for earlier signs of ALS so that future treatments can be delivered before extensive neurological damage occurs.
Topic
- September 26, 2018
Columbia neurologists found that a test used to measure Alzheimer's disease proteins in spinal fluid can be used to determine whether patients have the disease or other forms of dementia.
Topic
- September 18, 2018
A newly discovered function for the ApoE4 gene, the strongest genetic risk factor for Alzheimer’s disease, may help explain how the gene causes cognitive decline.
Topic
- September 18, 2018
A new anti-inflammatory drug may offer hope for people with a progressive form of MS. In a phase 2 trial, the drug slowed brain atrophy in people with the disease.
Topic
- September 5, 2018
A new study suggests that, among older adults, cognitive performance changes with the seasons and peaks in late summer.
Topic
